Drug Safety and Pharmacovigilance

Tracks 11 :Drug Safety and Pharmacovigilance

Drug safety relates to the potential for adverse effects related to the administration of drugs. Efforts to establish the safely profile of drugs begin early in their development, with in vitro and in vivo toxicity testing, and continue through clinical trials leading up to drug approval and following approval in specific post-marketing studies or general pharmacovigilance efforts. Pharmacovigilance (PV or PhV), also known as drug safety,is the pharmacological science relating to the collection, detection, assessment, monitoring, and prevention of adverse effects with pharmaceutical products.The etymological roots for the word "pharmacovigilance" are: pharmakon (Greek for drug) and vigilare (Latin for to keep watch). As such, pharmacovigilance heavily focuses on adverse drug reactions, or ADRs, which are defined as any response to a drug which is noxious and unintended, including lack of efficacy (the condition that this definition only applies with the doses normally used for the prophylaxis, diagnosis or therapy of disease, or for the modification of physiological disorder function was excluded with the latest amendment of the applicable legislation). Medication errors such as overdose, and misuse and abuse of a drug as well as drug exposure during pregnancy and breastfeeding, are also of interest, even without an adverse event, because they may result in an adverse drug reaction Signal Detection in Drug Safety

    Related Conference of Drug Safety and Pharmacovigilance

    December 02-03, 2020

    2nd International Conference on Bio-Pharmaceuticals

    Auckland, Newzealand
    December 07-08, 2020

    International Conference on Biotechnology and Healthcare

    Auckland, Newzealand
    December 16-16, 2020

    21st World Conference on Pharmaceutical Chemistry and Drug Design

    Singapore City, Singapore
    December 16-16, 2020

    22nd World Congress on Pharmacology, Nursing and Healthcare

    Algeria, Algeria
    January 22-23, 2021

    1 st Global Summit on Generic Drugs and Quality Control

    Prague, Czech Republic
    January 22-23, 2021

    1 st World Congress on Rare Diseases & Orphan Drugs

    Prague, Czech Republic
    February 26-27, 2021

    2nd Annual Congress on Antibiotics and Bacterial Infections

    Geneva, Switzerland
    March 10-11, 2021

    6th Pharmaceutical Chemistry Conference

    Paris, France
    March 16-17, 2021

    14th Global Pharmacovigilance And Clinical Trials Summit

    Albufeira, Portugal
    April 11-12, 2021

    2 nd World Pharma Expo

    Tokyo, Japan
    April 12-13, 2021

    2nd International Conference on Biosimilars & Pharmaceuticals

    Auckland, Newzealand
    April 28-29, 2021

    31st Annual European Pharma Congress

    London, UK
    April 28-29, 2021

    14th European Biosimilars Congress

    London, UK
    May 10-11, 2021

    20th Annual Meet on Pharmaceutical Sciences

    Yokohama, Japan
    May 17-18, 2021

    8th European Biopharma Congress

    Prague, Czech Republic
    May 19-20, 2021

    36th World Pharmacology and Therapeutics Forum

    Singapore, Singapore
    June 07-08, 2021

    2rd European Conference on Pharmacovigilance and Drug Safety

    Prague, Czech Republic
    July 10-11, 2021

    2 nd Pharma Expo China

    Tokyo, Japan
    August 16-17, 2021

    Global summit on Cosmetic & Reconstructive Surgery

    Tokyo, Japan
    August 16-17, 2021

    34rd World Congress on Pharmacology

    London, UK
    October 29-30, 2021

    14th World Drug Delivery Summit

    Vancouver, Canada
    October 29-30, 2021

    12th Annual Biomarkers and Clinical Research Congress

    Vancouver, Canada

    Drug Safety and Pharmacovigilance Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in